A young patient wakes up stuck in bed. It isn’t a lack of motivation or a desire for more sleep. Instead, they are unable to move their body, sometimes for minutes, sometimes for hours, upon waking. These episodes usually happen in the morning, leaving the patient frozen in their sleeping position with nothing to do but think: Was it something I ate? Did I play a little too much?
While they search for answers, they remain powerless to move. In some cases, they may even struggle to swallow or breathe. Although these paralysis attacks may not happen every day, they occur often enough to create constant anxiety about when the next episode will strike.
This pattern of episodic weakness is characteristic of a rare inherited muscle disorder known as periodic paralysis. This autosomal dominant condition is associated with genetic mutations in the calcium, sodium, and potassium channels within skeletal muscle. These channel dysfunctions lead to transient paralysis attacks, often triggered by changes in serum potassium levels.
Types of Periodic Paralysis
The two main types of periodic paralysis are classified by serum potassium levels during an attack.
Hypokalemic periodic paralysis is caused by abnormally low serum potassium. It most commonly affects patients younger than 20 years of age. Paralysis attacks tend to be severe (lasting hours to days) and frequently occur upon waking in the morning.
Hyperkalemic periodic paralysis is caused by abnormally high serum potassium levels and typically presents in patients younger than 10 years old. Attacks are usually shorter (lasting minutes to hours), vary in severity, and may be accompanied by muscle stiffness.
A third and rarer type is Andersen-Tawil syndrome (ATS), which usually presents before the age of 20. ATS is characterized by a triad of features including periodic paralysis (which may be hypokalemic or hyperkalemic), cardiac arrythmias, and facial dysmorphia.
In addition, periodic paralysis is an uncommon complication of hyperthyroidism (most notably Graves’ disease) known as thyrotoxic periodic paralysis.
Diagnosing Periodic Paralysis
On clinical examination, patients often show proximal muscle atrophy and residual weakness, particularly in the lower limbs. During an acute attack, deep tendon reflexes may be diminished or absent and myotonia (usually in the legs and extraocular muscles) may also be present.
If a focal paralysis episode needs to be induced for diagnostic purposes, patients may undergo exercise testing while an electromyograph (EMG) measures electrical activity in the affected muscles. Measuring serum potassium levels during exercises or immediately after an attack can help to detect hypokalemia (less than 3 mEq/L or 3 mmol/L) or hyperkalemia (greater than 5 mEq/L or 5 mmol/L).
While a clinical exam can strongly suggest periodic paralysis, genetic testing is required to confirm the diagnosis. Pathogenic variants are commonly found in the CACNA1S gene (associated with both hypokalemic or hyperkalemic periodic paralysis) or the SCN4A gene (more often linked to hyperkalemic periodic paralysis). Andersen-Tawil syndrome is confirmed by identifying a pathogenic KCNJ2 gene variant. Alongside genetic testing, patients may undergo a thyroid function test as patients with Graves’ disease may not exhibit the classic symptoms of thyrotoxicosis.
ATS can often be differentiated from other types of periodic paralyses by characteristic dental and craniofacial abnormalities. An electrocardiogram (ECG) is also required to detect cardiac arrythmias associated with the syndrome.
Management Strategies and Prognosis
Effective management of periodic paralysis combines preventive measures with targeted acute treatment to reduce the frequency, severity, and duration of attacks. Prophylaxis may include lifestyle modifications and pharmacologic therapy, such as carbonic anhydrase inhibitors (CAIs) that might reduce attack frequency.
Patients are advised to avoid common triggers if possible, including stress, sleep deprivation, night-shift work, irregular meals, and disrupted sleep cycles. Maintaining a regular routine, adequate hydration, and moderate exercise earlier in the day (with proper warm-up and cool-down periods) can also help reduce attacks.
Trigger avoidance and treatment strategies differ depending on the specific type of periodic paralysis.
Patients with hypokalemic periodic paralysis should avoid prolonged rest after heavy exercise, any alcohol consumption, and diets high in sodium or carbohydrates, and potassium supplements. Patients should also focus on staying hydrated. While potassium supplementation may be required, it must be carefully managed. Potassium-sparing diuretics can also help maintain stable serum potassium levels.
Patients with hyperkalemic periodic paralysis are advised to avoid potassium-rich foods, exposure to cold temperatures, and prolonged fasting. Excessive exercise followed by rest may also trigger attacks. In some cases, potassium-wasting diuretics may be prescribed to help normalize serum potassium.
During acute paralysis attacks, mild exercise alongside condition-specific management may help reduce the severity of an oncoming attack. Hypokalemic attacks usually require oral or intravenous potassium replacement whereas hyperkalemic episodes may be treated with carbohydrates, calcium gluconate, or beta-2 agonists during severe attacks.
Patients with Andersen-Tawil syndrome require additional management of cardiac arrythmias, which may include beta-blockers or implantation of a cardioverter defibrillator. When periodic paralysis is a complication of Graves’ disease, it is essential to control the underlying thyroid dysfunction.
Living With Periodic Paralysis
Although periodic paralysis is a challenging clinical conundrum, appropriate diagnosis and management can markedly reduce the frequency and severity of attacks. Symptoms often improve with age, particularly as younger patients reach adulthood. Some individuals may be left with mild, permanent muscle weakness depending on the cumulative burden of prior attacks.
For the patient with hypokalemic periodic paralysis described at the beginning of this article, effective treatment reduced both the severity and frequency of attacks and the anxiety caused by their unpredictability. Over time, the individual will be able to wake up without fear of being trapped in their own bed.
